Table 3

Sensitivity analysis

VariablePoint prevalence (%)95% CICumulative incidence per 10 00095% CI
All1.05(1.03 to 1.07)17.7(16.9 to 18.6)
Education (years)
 0–91.24(1.20 to 1.28)19.0(17.4 to 20.6)
 10–121.09(1.06 to 1.12)19.0(17.6 to 20.4)
 13–140.91(0.85 to 0.97)14.4(11.8 to 17.0)
 15+0.75(0.70 to 0.79)13.3(11.2 to 15.4)
Income
 Low1.04(0.98 to 1.10)18.4(15.8 to 21.0)
 Middle1.15(1.12 to 1.18)18.8(17.6 to 19.9)
 High0.85(0.80 to 0.90)15.4(13.1 to 17.7)
Occupation
 White, high0.92(0.88 to 0.96)16.0(14.2 to 17.7)
 White, low1.07(1.01 to 1.14)18.0(15.3 to 20.6)
 Blue, high1.09(1.00 to 1.17)18.4(14.9 to 21.8)
 Blue, low1.17(1.10 to 1.23)18.9(16.0 to 21.8)
  • The 2013 point prevalence and cumulative incidence of gout age and sex standardised to the whole Skåne population (ie, proportions represent what would have been observed if the age and sex distribution in each group was as in the general population). A more stringent definition of gout is, any M10 diagnostic code according to the ICD-10 registered at least once by a physician within secondary care (internal medicine or rheumatology) or at least twice by any other physician.

  • ICD-10, International Classification of Diseases 10th Edition.